Amgen Inc. (AMGN) Tops Q1 EPS by 5c, Reaffirms Outlook
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $440.34 --0%
Financial Fact:
Research and development: 990M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Financial Fact:
Research and development: 990M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Join SI Premium – FREE
Amgen Inc. (NASDAQ: AMGN) reported Q1 EPS of $1.34, $0.05 better than the analyst estimate of $1.29. Revenue for the quarter came in at $3.7 million versus the consensus estimate of $3.68 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
- Agilent Technologies (A) Tops Q3 EPS by 13c, Beats on Revenue; Offers FY EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
